RNA-seq of the CP in other neurological diseases such as frontotemporal dementia, Alzheimer’s and Huntington’s disease [70], or schizophrenia [34] revealed alterations in the barrier or immune homeostatic properties of the CP. This evidence concerns the gene CP and nervous system disorder.